FDA Inspection 1322452 — RxCrossroads 3PL LLC
The FDA completed an inspection of RxCrossroads 3PL LLC on June 9, 2026 in Shepherdsville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 9, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Shepherdsville, KY (United States)